← Back to Search

Behavioural Intervention

Mindfulness-Based Stress Reduction for Chronic Pain (OPTIMUM Trial)

N/A
Waitlist Available
Led By Natalia Morone, MD, MS
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18
Chronic low back pain, which is pain that persists for at least 3 months and has resulted in pain on at least half the days in the past 6 months
Must not have
Metastatic cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks, 6 months,12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether a mindfulness-based stress reduction program can improve function for people with chronic low back pain.

Who is the study for?
This trial is for adults over 18 with chronic low back pain lasting at least 3 months, experiencing pain on most days in the past half year. Participants must score ≥3 on the PEG scale, speak English, and be able to consent online or by phone. Excluded are those with recent severe symptoms, pregnancy, metastatic cancer, relatives of OPTIMUM study participants or non-patients of participating clinics.
What is being tested?
The trial tests if group medical visits using mindfulness-based stress reduction can improve function in people with chronic low back pain compared to usual care from their primary care provider (PCP). It's part of the 'OPTIMUM' program designed for such conditions.
What are the potential side effects?
Mindfulness-based interventions typically have minimal side effects; however, some individuals may experience emotional discomfort when confronting painful thoughts and feelings during practice.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have had lower back pain for at least 3 months, with pain on most days in the last 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks, 6 months,12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks, 6 months,12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain intensity and interference at Baseline, 8 weeks, 6 months (primary timepoint), & 12 months: PEG score
Secondary study objectives
Amount of opioid pain medication
Anxiety at Baseline
Chronic overlapping pain at 8 weeks
+18 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness Pain Program + Usual PCP CareExperimental Treatment2 Interventions
Participants will undergo 8 weekly 90 minute sessions of Mindfulness-Based Stress Reduction in addition to receiving usual PCP care for chronic lower back pain.
Group II: Usual PCP CareActive Control1 Intervention
Participants will receive usual PCP care for chronic lower back pain.

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
405 Previous Clinical Trials
884,510 Total Patients Enrolled
6 Trials studying Chronic Pain
1,108 Patients Enrolled for Chronic Pain
National Center for Complementary and Integrative Health (NCCIH)NIH
867 Previous Clinical Trials
674,520 Total Patients Enrolled
50 Trials studying Chronic Pain
20,039 Patients Enrolled for Chronic Pain
Natalia Morone, MD, MSPrincipal InvestigatorBoston Medical Center
2 Previous Clinical Trials
116 Total Patients Enrolled

Media Library

Group-based Mindfulness (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04129450 — N/A
Chronic Pain Research Study Groups: Mindfulness Pain Program + Usual PCP Care, Usual PCP Care
Chronic Pain Clinical Trial 2023: Group-based Mindfulness Highlights & Side Effects. Trial Name: NCT04129450 — N/A
Group-based Mindfulness (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04129450 — N/A
~0 spots leftby Dec 2024